Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.2250
-0.0050 (-2.22%)
Mar 6, 2026, 3:54 PM GMT
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 15.31 million as of March 6, 2026. Its market cap has increased by 281.16% in one year.
Market Cap
15.31M
Enterprise Value
13.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 15.31M, a decrease of -33.51%. That is a compound annual growth rate of -9.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 15.31M | -27.42% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Weir Group | 8.76B |
| Smiths Group | 8.41B |
| Melrose Industries | 6.78B |
| IMI plc | 6.73B |
| Spirax Group | 5.52B |
| Rotork | 3.14B |
| Goodwin | 1.73B |
| Bodycote | 1.24B |